| | Morphology | Gender | All-age deaths (95% UI), no. 103(95% UI) | Age-standardized mortality rate (95% UI), per 100,000 | | 1990 | 2019 | Change, % | 1990 | 2019 | Change, % |
| | All neoplasms | Male | 868.85 (677.58, 1053.30) | 1704.14 (1336.21,2112.01) | 96.14 | 220.49 (175.99,264.00) | 192.28(152.49,234.84) | -12.79 | | Female | 543.87 (426.76, 667.64) | 936.05 (722.95,1154.37) | 72.11 | 126.62 (100.21,154.35) | 92.65 (71.67,113.95) | -26.82 | | Both | 1412.72 (1164.05,1661.26) | 2640.20 (2174.68, 3131.22) | 86.89 | 168.81 (140.27,196.93) | 136.72(112.97,161.19) | -19.01 |
| | Tracheal, bronchus, and lung cancer | Male | 177.93 (145.87,214.39) | 523.19 (413.19,647.41) | 194.04 | 46.33 (38.78,55.03) | 58.1 (46.53,70.89) | 25.40 | | Female | 78.4 (65.03,91.66) | 233.98 (189.18,282.75) | 198.44 | 18.63 (15.62,21.64) | 22.86 (18.52,27.52) | 22.71 | | Both | 256.33 (221.06,294.56) | 757.17 (638.74,887.75) | 195.39 | 31.18 (27.14,35.52) | 38.7 (32.8,45.03) | 24.12 |
| | Stomach cancer | Male | 197.06 (161.82,232.16) | 298.51 (238.47,363.78) | 51.48 | 51.36 (42.96,59.94) | 33.14 (26.67,39.89) | -35.48 | | Female | 108.41 (90.42,126.30) | 123.03(99.95,150.64) | 13.49 | 26.17 (21.94,30.37) | 12.20 (9.93,14.92) | -53.38 | | Both | 305.47 (267.21,345.40) | 421.54 (353.52,493.18) | 38.00 | 37.73 (33.20,42.39) | 21.72 (18.31,25.31) | -42.43 |
| | Colorectal cancer | Male | 42.02 (34.9,49.40) | 164.73 (132.24,202.32) | 292.03 | 11.73 (9.95,13.59) | 19.32 (15.8,23.15) | 64.71 | | Female | 37.30 (31.31,43.32) | 97.05 (78.38,117.17) | 160.19 | 9.14 (7.73,10.58) | 9.68 (7.82,11.68) | 5.91 | | Both | 79.32 (69.66,89.29) | 261.78 (224.4,303.32) | 230.03 | 10.18 (9.03,11.37) | 13.86 (11.92,16.01) | 36.15 |
| | Esophageal cancer | Male | 117.08 (73.11,141.72) | 197.72 (151.48,246.01) | 68.88 | 30.53 (19.80,36.44) | 21.69 (16.61,26.66) | -28.96 | | Female | 59.52 (33.27,70.74) | 59.6 (40.46,74.97) | 0.13 | 14.69 (8.39,17.38) | 5.92 (3.98,7.45) | -59.70 | | Both | 176.60 (112.85,206.04) | 257.32 (202.78,309.03) | 45.71 | 22.08 (14.14,25.53) | 13.15 (10.27,15.68) | -40.44 |
| | Liver cancer | Male | 164.91 (132.61,201.69) | 139.03 (109.61,172.17) | -15.69 | 36.65 (29.77,44.3) | 14.56 (11.63,17.86) | -60.27 | | Female | 67.54 (54.69,83.09) | 48.67 (38.97,59.42) | -27.94 | 15.57 (12.70,19.04) | 4.76 (3.81,5.80) | -69.43 | | Both | 232.45 (197.40,275.39) | 187.7 (158.26,222.77) | -19.25 | 25.99 (22.29,30.55) | 9.41 (7.95,11.13) | -63.79 |
| | Prostate cancer | Male | 20.38 (15.82,24.68) | 54.39 (42.9,71.31) | 166.88 | 8.22 (6.62,10.28) | 7.79 (6.22,9.94) | -5.23 |
| | Pancreatic cancer | Male | 15.87 (12.94,19.23) | 70.22 (55.62,86.99) | 342.47 | 4.12 (3.42,4.91) | 7.69 (6.15,9.41) | 86.65 | | Female | 11.24 (9.46,13.07) | 47.16 (38.00,57.33) | 319.57 | 2.70 (2.28,3.13) | 4.58 (3.70,5.56) | 69.63 | | Both | 27.10 (23.6,30.84) | 117.37 (99.86,136.45) | 333.10 | 3.34 (2.93,3.76) | 5.99 (5.12,6.93) | 79.34 |
| | Cervical cancer | Female | 26.42 (20.52,43.53) | 53.44 (30.4,68.86) | 102.27 | 5.85 (4.59,9.57) | 5.13 (2.92,6.6) | -12.31 |
| | Breast cancer | Male | 0.37 (0.30,0.45) | 2.81 (2.15,3.53) | 659.46 | 0.10 (0.08,0.12) | 0.29 (0.22,0.36) | 190.00 | | Female | 41.43 (34.15,49.15) | 93.5 (74.51,115.42) | 125.68 | 9.16 (7.61,10.82) | 9.02 (7.19,11.10) | -1.53 | | Both | 41.80 (34.55,49.51) | 96.31 (77.32,118.09) | 130.41 | 4.74 (3.96,5.57) | 4.85 (3.91,5.92) | 2.32 |
| | Leukemia | Male | 36.39 (25.18,43.85) | 35.22 (26.33,44.01) | -3.22 | 6.88 (5.02,8.25) | 4.42 (3.36,5.4) | -35.76 | | Female | 30.43 (24.36,37.13) | 25.16 (19.08,31.27) | -17.32 | 5.83 (4.72,7.03) | 3.00 (2.30,3.67) | -48.54 | | Both | 66.82 (54.35,77.29) | 60.38 (50.21,70.99) | -9.64 | 6.28 (5.18,7.26) | 3.67 (3.07,4.28) | -41.56 |
| | Brain and central nervous system cancer | Male | 21.26 (14.5,31.89) | 35.65 (22.01,47.44) | 67.69 | 4.35 (3.02,6.46) | 4.05 (2.53,5.33) | -6.90 | | Female | 16.71 (11.63,22.37) | 27.88 (20.2,36.13) | 66.85 | 3.44 (2.44,4.58) | 3.01 (2.19,3.88) | -12.50 | | Both | 37.97 (29.10,50.21) | 63.53 (47.79,76.95) | 67.32 | 3.87 (3.04,5.10) | 3.5 (2.62,4.21) | -9.56 |
| | Ovarian cancer | Female | 8.04 (6.18,11.67) | 29.09 (20.96,36.86) | 261.82 | 1.76 (1.36,2.59) | 2.77 (2.01,3.5) | 57.39 |
| | Non-Hodgkin lymphoma | Male | 9.45 (7.82,11.25) | 29.12 (23.22,36.03) | 208.15 | 2.16 (1.80,2.54) | 3.19 (2.57,3.90) | 47.69 | | Female | 6.98 (5.85,8.17) | 15.19 (12.22,18.58) | 117.62 | 1.53 (1.30,1.79) | 1.55 (1.25,1.88) | 1.31 | | Both | 16.44 (14.40,18.59) | 44.31 (37.46,51.97) | 169.53 | 1.82 (1.61,2.05) | 2.32 (1.97,2.70) | 27.47 |
| | Bladder cancer | Male | 11.91 (9.94,13.77) | 31.5 (25.60,38.33) | 164.48 | 4.43 (3.79,5.04) | 4.30 (3.56,5.12) | -2.93 | | Female | 5.38 (4.46,6.42) | 8.59 (6.92,10.52) | 59.67 | 1.45 (1.22,1.73) | 0.88 (0.71,1.08) | -39.31 | | Both | 17.29 (15.09,19.45) | 40.09 (33.98,47.18) | 131.87 | 2.58 (2.26,2.90) | 2.24 (1.91,2.61) | -13.18 |
| | Gallbladder and biliary tract cancer | Male | 5.44 (4.31,9.16) | 17.76 (12.88,22.42) | 226.47 | 1.62 (1.33,2.59) | 2.09 (1.53,2.6) | 29.01 | | Female | 6.64 (5.14,11.48) | 16.70 (10.30,21.30) | 151.51 | 1.66 (1.29,2.84) | 1.64 (1.01,2.09) | -1.20 | | Both | 12.08 (9.98,19.48) | 34.46 (25.22,41.23) | 185.26 | 1.61 (1.35,2.54) | 1.82 (1.32,2.17) | 13.04 |
| | Nasopharynx cancer | Male | 17.43 (14.3,20.73) | 21.35 (16.67,26.47) | 22.49 | 3.86 (3.21,4.55) | 2.20 (1.74,2.70) | -43.01 | | Female | 9.14 (7.28,11.02) | 7.31 (5.7,9.04) | -20.02 | 2.01 (1.61,2.42) | 0.72 (0.56,0.89) | -64.18 | | Both | 26.57 (22.77,30.28) | 28.66 (23.78,34.07) | 7.87 | 2.9 (2.51,3.3) | 1.43 (1.19,1.69) | -50.69 |
| | Kidney cancer | Male | 3.33 (2.73,4.07) | 16.88 (13.18,20.84) | 406.91 | 0.85 (0.7,1.01) | 1.96 (1.55,2.38) | 130.59 | | Female | 2.55 (2.19,2.94) | 7.07 (5.68,8.62) | 177.25 | 0.59 (0.50,0.67) | 0.72 (0.59,0.87) | 22.03 | | Both | 5.88 (5.14,6.69) | 23.95 (19.77,28.48) | 307.31 | 0.7 (0.61,0.79) | 1.27 (1.05,1.49) | 81.43 |
| | Uterine cancer | Female | 10.60 (7.95,13.04) | 12.22 (9.42,17.34) | 15.28 | 2.38 (1.81,2.90) | 1.17 (0.90,1.66) | -50.84 |
| | Lip and oral cavity cancer | Male | 4.57 (3.72,5.45) | 17.61 (14.09,21.90) | 285.34 | 1.23 (1.02,1.44) | 1.95 (1.59,2.40) | 58.54 | | Female | 2.83 (2.36,3.33) | 5.03 (4.06,6.12) | 77.74 | 0.69 (0.57,0.80) | 0.50 (0.41,0.61) | -27.54 | | Both | 7.40 (6.44,8.36) | 22.64 (18.91,27.08) | 205.95 | 0.92 (0.81,1.03) | 1.16 (0.98,1.38) | 26.09 |
| | Larynx cancer | Male | 8.90 (7.24,10.49) | 16.84 (13.50,20.73) | 89.21 | 2.34 (1.94,2.72) | 1.82 (1.47,2.21) | -22.22 | | Female | 2.59 (2.18,3.00) | 3.42 (2.74,4.13) | 32.05 | 0.62 (0.52,0.71) | 0.34 (0.27,0.4) | -45.16 | | Both | 11.50 (9.85,13.24) | 20.25 (16.76,24.23) | 76.09 | 1.40 (1.21,1.60) | 1.02 (0.85,1.21) | -27.14 |
| | Non-melanoma skin cancer | Male | 2.69 (2.23,3.13) | 7.98 (6.49,9.66) | 196.65 | 0.88 (0.74,1) | 1.05 (0.87,1.24) | 19.32 | | Female | 2.29 (1.90,2.72) | 7.50 (5.78,9.17) | 227.51 | 0.59 (0.50,0.70) | 0.77 (0.60,0.94) | 30.51 | | Both | 4.98 (4.36,5.60) | 15.48 (13.10,17.80) | 210.84 | 0.70 (0.61,0.78) | 0.88 (0.74,1.01) | 25.71 |
| | Multiple myeloma | Male | 2.60 (1.96,3.91) | 7.71 (4.96,10.24) | 196.54 | 0.65 (0.5,0.98) | 0.83 (0.54,1.08) | 27.69 | | Female | 2.74 (2.06,4.07) | 5.71 (4.08,7.46) | 108.39 | 0.64 (0.48,0.94) | 0.55 (0.39,0.71) | -14.06 | | Both | 5.34 (4.35,7.53) | 13.42 (10.06,16.5) | 151.31 | 0.64 (0.53,0.89) | 0.67 (0.50,0.82) | 4.69 |
| | Thyroid cancer | Male | 1.23 (1.00,1.52) | 4.21 (3.18,5.24) | 242.28 | 0.35 (0.29,0.43) | 0.52 (0.40,0.64) | 48.57 | | Female | 2.09 (1.71,2.68) | 3.03 (2.40,3.76) | 44.98 | 0.50 (0.41,0.63) | 0.30 (0.24,0.38) | -40.00 | | Both | 3.32 (2.86,4.13) | 7.24 (6.01,8.48) | 118.07 | 0.42 (0.37,0.53) | 0.39 (0.32,0.45) | -7.14 |
| | Other pharynx cancer | Male | 2.26 (1.86,2.67) | 4.60 (3.55,5.74) | 103.54 | 0.58 (0.49,0.69) | 0.49 (0.38,0.6) | -15.52 | | Female | 0.73 (0.60,0.87) | 0.99 (0.79,1.21) | 35.62 | 0.17 (0.14,0.20) | 0.10 (0.08,0.12) | -41.18 | | Both | 2.99 (2.57,3.44) | 5.59 (4.53,6.73) | 86.96 | 0.36 (0.31,0.41) | 0.28 (0.23,0.33) | -22.22 |
| | Malignant skin melanoma | Male | 1.45 (0.88,2.02) | 2.5 (1.45,3.47) | 72.41 | 0.34 (0.22,0.48) | 0.29 (0.17,0.40) | -14.71 | | Female | 1.32 (0.81,2.19) | 2.66 (1.42,3.64) | 101.52 | 0.31 (0.20,0.51) | 0.27 (0.15,0.37) | -12.90 | | Both | 2.76 (1.90,4.06) | 5.16 (3.28,6.50) | 86.96 | 0.33 (0.23,0.48) | 0.28 (0.18,0.35) | -15.15 |
| | Testicular cancer | Male | 0.78 (0.65,0.91) | 1.21 (0.96,1.47) | 55.13 | 0.16 (0.13,0.18) | 0.16 (0.13,0.19) | 0.00 |
| | Hodgkin lymphoma | Male | 3.03 (1.45,4.01) | 1.76 (1.18,2.35) | -41.91 | 0.65 (0.31,0.85) | 0.20 (0.13,0.26) | -69.23 | | Female | 1.92 (0.83,2.68) | 0.95 (0.64,1.23) | -50.52 | 0.40 (0.18,0.55) | 0.10 (0.07,0.13) | -75.00 | | Both | 4.95 (2.57,6.47) | 2.71 (2.00,3.29) | -45.25 | 0.52 (0.27,0.67) | 0.15 (0.11,0.18) | -71.15 |
| | Mesothelioma | Male | 0.51 (0.40,0.74) | 1.65 (1.29,2.14) | 223.53 | 0.12 (0.10,0.18) | 0.18 (0.14,0.23) | 50.00 | | Female | 0.62 (0.41,1.02) | 1.12 (0.72,1.44) | 80.65 | 0.14 (0.10,0.23) | 0.11 (0.07,0.14) | -21.43 | | Both | 1.13 (0.86,1.59) | 2.77 (2.28,3.32) | 145.13 | 0.13 (0.10,0.19) | 0.14 (0.12,0.17) | 7.69 |
|
|
